Navigation Links
West to Co-present Research Findings on Understanding the Patient Journey through the Phases of a Chronic Disease
Date:11/1/2013

EXTON, Pa., Nov. 1, 2013 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has completed primary user research with its partner, Insight Product Development, aimed at understanding the needs of patients, caregivers and clinicians in the field of injectable therapies for chronic diseases. West will co-present a poster summarizing the findings at the Parenteral Drug Association (PDA) conference on "The Universe of Prefilled Syringes and Injection Devices" in Basel, Switzerland November 5-6.

Chris Evans, Director of Innovation at West, and Craig Scherer, Senior Partner of Insight, will present at 10:45 a.m. on November 5 and during session breaks throughout both days of the conference.

With the increase in chronic conditions such as diabetes and autoimmune diseases (such as rheumatoid arthritis and multiple sclerosis) it is becoming more critical to provide safe and effective drug delivery systems that can be used by the patient for self-administration in the home environment. West provides a number of solutions to support the packaging and delivery of these conditions, and realizes the importance of ensuring a deep understanding of patients' needs. This is essential to ensure that systems are provided that optimize patient experience and improve outcomes through the patient's journey from initial diagnosis to a point of being in control of their treatment.

"Effective drug delivery is no longer just about the drug molecule," said Graham Reynolds, Vice President of Marketing and Innovation at West. "We recognize that a medicine can be truly effective only if it is contained and delivered safely,
'/>"/>

SOURCE West Pharmaceutical Services, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. IBM Research and Institute of Bioengineering and Nanotechnology Discover Breakthrough for Breast Cancer Drug Delivery
2. Research by ClinMet Scientific Founder and Colleagues Point to Enzyme that Restores Function in Diabetic Kidney Disease
3. PRA Staff Named Finalists in Clinical Researcher of the Year Competition
4. McCord Research Appoints Wound Care Education Expert
5. Neurology Devices Market is Expected to Reach USD 13.6 Billion Globally in 2019: Transparency Market Research
6. Medical Imaging Equipment Market is Expected to Reach USD 35.35 Billion Globally in 2019: Transparency Market Research
7. Philanthropic Grants, Product Launches, Promising Partnerships, and Customer Satisfaction Rankings - Research Report on CVS Caremark, Walgreens, McKesson, AmerisourceBergen, and Cardinal Health
8. Life Technologies Awards Digital PCR Innovation Grants to Five Research Labs
9. Kaiser Permanente Researchers Honored for Drug Therapy Study
10. InCube Labs Enters into an Agreement with the Engineering Research Center for Revolutionizing Metallic Biomaterials
11. Healthcare Sector Announced Clinical Data Presentation, Upcoming Financial Release Schedules and Updates on New Drug Applications - Research Report on Alexion, Pacira, pSivida, Momenta and Impax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... R.I. , Jan. 15, 2014 MultiCell Technologies, ... filed a U.S. provisional patent application concerning composition of ... to achieve targeted tumor cell death.  ... small noncoding double stranded RNA molecules (VSRNAs) which interfere ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
(Date:1/15/2014)... Pharmaceuticals International, Inc. (NYSE: VRX and ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") with ... indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ("Purchaser"), for all ... Medical, Inc. (NASDAQ: SLTM ) ("Solta") at ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
... Capecitabine More Than Doubles Time to Progression and Overall Response ... + Placebo in Patients with 2nd or 3rd Line Metastatic ... Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) yesterday announced ... Akt-inhibitor for cancer, in combination with capecitabine as a treatment ...
... , New study finds patients who opt for surgery have decreased ... People with the spine disease called degenerative spondylolisthesis ... from pain over time compared to those who do not have ... of The Journal of Bone and Joint Surgery ...
Cached Medicine Technology:Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 2Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 3Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 4Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 5Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 6Back to Normal: Surgery Improves Outcomes for Spine Patients 2Back to Normal: Surgery Improves Outcomes for Spine Patients 3Back to Normal: Surgery Improves Outcomes for Spine Patients 4
(Date:7/10/2014)... far outweigh the risks when children receive The Right ... Dose. However, overuse and misuse of imaging change the ... effort to ensure a national protocol is put into ... of Patient Safety , calls for the American College ... and the Centers for Medicare & Medicaid Services to ...
(Date:7/10/2014)... more severe illness and even death are likely to ... developing influenza. Now, however, a team of researchers based ... reverse the order of infection, the bacteria Streptococcus ... a bad case of the flu. , The ... described as a bacterial virulence factor, might protect macrophagesa ...
(Date:7/10/2014)... Rutgers University-Newark says the human brain operates much the ... that could provide a better understanding of schizophrenia, bipolar ... an estimated 13.6 million Americans. , In newly published ... an assistant professor at the Center for Molecular and ... a person at rest is basically the same as ...
(Date:7/10/2014)... with localized prostate cancer were more likely to ... less effective treatments and survived for shorter times ... a UCLA study has found. , The negative ... such as bias against the mentally ill, depression,s ... lack of investment in his general health and ...
(Date:7/10/2014)... are just as tempting as full-fat equivalents could ... insights into how proteins can replace fats without ... by the Engineering and Physical Sciences Research Council ... University of Edinburgh has produced modified proteins that ... mimic the behaviour of fats during food manufacture. ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic calls for standardization of safe imaging protocols for children 2Health News:Bacterial colonization prior to catching the flu may protect against severe illness 2Health News:Working to loosen the grip of severe mental illness 2Health News:Depressed men with prostate cancer are diagnosed later stage, get less effective therapies 2Health News:Great tasting low-fat cheeses and cakes could soon be on the menu 2
... 5, 2008/Saranac Lake, N.Y.-- On May 12, 2008, the ... in their Distinguished Americans series. The stamp, the eleventh ... (1848-1915). Stamp collecting is one of the most popular ... 20 million American collectors participating in the activity. The ...
... PRINCETON, N.J., May 7 Patients, nurses,physicians and other ... on the State House May 12 to protest the ... 2009 state budget,plan., WHAT: "Care Today, Gone Tomorrow," ... House steps, West State Street, Trenton, WHEN: 12 ...
... from Caring.com Now Available to Thousands ... of Pennsylvanians Caring for an Aging Parent, ... to,announce a partnership with Trib Total Media, publisher of ... the,magazine,s new online companion. The new online resource,( http://pacaregiver.caring.com ...
... HMS Holdings Corp. (Nasdaq:,HMSY) today announced that it ... which will be held May 13-15, 2008 at the ... CEO, and Walter Hosp, Chief Financial,Officer of HMS Holdings ... PT., HMS Holdings Corp. (Nasdaq: HMSY ) ...
... families in Mexico support innovations to extend the local, productive impact of remittances shines ... ... in Mexico and the US. - Broad, support in communities of origin for ... money from the US. -, Family members in Mexico would encourage senders ...
... leads $12 Million in Series A First Tranche Financing, ... NGN Capital announced,today the formation of ACT Biotech Inc., ... cancer drugs. ACT Biotech has,entered into a license agreement ... early stage oncology assets. In conjunction with the,agreement, ACT ...
Cached Medicine News:Health News:New United States Postal Service stamp honors an American scientist 2Health News:New United States Postal Service stamp honors an American scientist 3Health News:Caring.com Partners With Trib Total Media to Support the Development of a New Online Eldercare Resource 2Health News:Recipients in Mexico Favor Receiving US-Sent Remittances Through Companies that Contribute to Local Economic Development and Job Creation Projects 2Health News:Recipients in Mexico Favor Receiving US-Sent Remittances Through Companies that Contribute to Local Economic Development and Job Creation Projects 3Health News:ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer Healthcare 2
The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence appl...
The essence of fluorescence analysis is sensitivity. The high throughput optical system in the RF-5301PC employs a blazed holographic grating, photomultiplier and digital signal processing to provide...
The new Gemini EM microplate spectrofluorometer builds on the successful Gemini platform. This next generation reader incorporates all of the high performance features of the Gemini XS with new capab...
... DNA, RNA, Or Fluorescent Tags. Accurate quantitation of ... to life science research. The RF-Mini 150 Fluorometer ... as small as 1ng/ml of DNA specific Hoechst ... and emission filters, the RF-Mini 150 can measure ...
Medicine Products: